Figure 5: Adjusted mean (95% CI) change from baseline in (A) PPG AUC (mg∙min/dL) and (B) 2-hour PPG (mg/dL) at week 24. Number of patients by treatment group and PPG AUC and 2-hour PPG outcomes. Data collected before receiving rescue medication. PPG-AUC and 2-hour PPG were evaluated by ANCOVA model with last observation carried forward to account for missing data. At week 24, changes from baseline in PPG AUC and 2-hour PPG were statistically significant with saxagliptin 2.5 mg and saxagliptin 5 mg vs placebo (P<0.001 for each dose). ANCOVA=analysis of covariance; AUC=area under the curve; PPG=postprandial glucose. *Number of randomized patients with baseline and week 24 values.